NeueHealth Closes $1.465B Acquisition by NEA and Investor Consortium

NeueHealth, a company that connects providers and payers with technology to enable value-based care, has completed its previously announced merger with an affiliate of New Enterprise Associates at an enterprise value of approximately $1.465 billion. The finalized acquisition represents a $165 million increase from the initially projected price when the deal was announced in January. Following the completion of the transaction, NeueHealth's stock ceased trading on the New York Stock Exchange as of October 2, with shares last trading at $6.75.

Under the terms of the agreement, holders of NeueHealth's common stock will receive $7.33 per share in cash. Certain stockholders, including NEA and 12 other existing investors, have signed rollover agreements through which their investments will be exchanged for equity in the now privately held company. NeueHealth's executive leadership team will continue in their current roles and have agreed to roll over 100% of their interests for newly issued equity interests in the private company, demonstrating confidence in the organization's future direction under private ownership.

"Since our founding, NeueHealth has been committed to aligning the interests of consumers, payors, and providers to create a seamless, more coordinated care experience for all," Mike Mikan, president and CEO of NeueHealth, said in a statement. "This transaction marks a significant milestone for our company as it allows us the flexibility and resources to continue to fulfill this mission as we advance our value-driven, consumer-centric care model and drive long-term, sustainable growth into the future."

The transaction follows NeueHealth's initial announcement in January when the company entered into a definitive merger agreement to be acquired by an affiliate of NEA at a value of $1.3 billion. The company's most recent financial performance, reported in its second-quarter 2025 earnings released in August, showed revenue of $209,082 compared to $225,991 in the same period the previous year. The company reported a net loss of $1,548 in the second quarter compared to a loss of $57,698 the year prior. Adjusted EBITDA showed improvement, reaching $19,020 in the second quarter of 2025 compared to $3,962 in the second quarter of 2024, indicating progress in operational efficiency despite the revenue decline.

Click here for the original news story.